GPR143: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}})) |
m (Bot: HTTP→HTTPS) |
||
Line 1: | Line 1: | ||
{{Infobox_gene}} | |||
{{ | {{Infobox protein family | ||
| | | Symbol = Ocular_alb | ||
| | | Name = Ocular albinism type 1 protein | ||
| | | image = | ||
| | | width = | ||
| | | caption = | ||
| Pfam = PF02101 | |||
| Pfam_clan = CL0192 | |||
| InterPro = IPR001414 | |||
| SMART = | |||
| PROSITE = | |||
| MEROPS = | |||
| SCOP = | |||
| TCDB = | |||
| OPM family = | |||
| OPM protein = | |||
| CAZy = | |||
| CDD = | |||
}} | }} | ||
'''G-protein coupled receptor 143''' is a [[protein]] encoded by the ''GPR143'' [[gene]] in humans.<ref name="pmid7647783">{{cite journal |vauthors=Bassi MT, Schiaffino MV, Renieri A, De Nigris F, Galli L, Bruttini M, Gebbia M, Bergen AA, Lewis RA, Ballabio A | title = Cloning of the gene for ocular albinism type 1 from the distal short arm of the X chromosome | journal = Nat Genet | volume = 10 | issue = 1 | pages = 13–9 |date=Sep 1995 | pmid = 7647783 | pmc = | doi = 10.1038/ng0595-13 }}</ref><ref name="pmid10471510">{{cite journal |vauthors=Schiaffino MV, d'Addio M, Alloni A, Baschirotto C, Valetti C, Cortese K, Puri C, Bassi MT, Colla C, De Luca M, Tacchetti C, Ballabio A | title = Ocular albinism: evidence for a defect in an intracellular signal transduction system | journal = Nat Genet | volume = 23 | issue = 1 | pages = 108–12 |date=Sep 1999 | pmid = 10471510 | pmc = | doi = 10.1038/12715 }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: GPR143 G protein-coupled receptor 143| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=4935| accessdate = }}</ref> | |||
[[Ocular albinism]] type 1 protein is a conserved integral membrane protein with seven transmembrane domains. It is expressed in the eye and epidermal melanocytes.<ref name="entrez"/> | |||
The GPR143 gene is regulated by the [[Microphthalmia-associated transcription factor]].<ref name="pmid15254223">{{cite journal |vauthors=Vetrini F, Auricchio A, Du J | title = The microphthalmia transcription factor (Mitf) controls expression of the ocular albinism type 1 gene: link between melanin synthesis and melanosome biogenesis | journal = Mol. Cell. Biol. | volume = 24 | issue = 15 | pages = 6550–9 | year = 2004 | pmid = 15254223 | doi = 10.1128/MCB.24.15.6550-6559.2004 | pmc = 444869 |display-authors=etal}}</ref><ref name="pmidunknown">{{cite journal |vauthors=Hoek KS, Schlegel NC, Eichhoff OM | title = Novel MITF targets identified using a two-step DNA microarray strategy | journal = Pigment Cell Melanoma Res. | volume = 21 | issue = 6 | pages = 665–76 | year = 2008 | pmid = 19067971| doi = 10.1111/j.1755-148X.2008.00505.x |display-authors=etal}}</ref> | |||
[[L-DOPA]] is an endogenous ligand for OA1.<ref name="pmid18828673">{{cite journal | vauthors = Lopez VM, Decatur CL, Stamer WD, Lynch RM, McKay BS | editor1-last = Barsh | editor1-first = Gregory S | title = L-DOPA is an endogenous ligand for OA1 | journal = PLoS Biol. | volume = 6 | issue = 9 | pages = e236 |date=September 2008 | pmid = 18828673 | pmc = 2553842 | doi = 10.1371/journal.pbio.0060236 | url = | issn = }}</ref> | |||
==Interactions== | |||
GPR143 has been shown to [[Protein-protein interaction|interact]] with [[GNAI1]].<ref name=pmid10471510 /> | |||
| | |||
==References== | ==References== | ||
{{ | {{Reflist}} | ||
==Further reading== | ==Further reading== | ||
{{ | {{Refbegin | 2}} | ||
*{{Cite journal |vauthors=Oetting WS, King RA |title=Molecular basis of albinism: mutations and polymorphisms of pigmentation genes associated with albinism. |journal=Hum. Mutat. |volume=13 |issue= 2 |pages= 99–115 |year= 1999 |pmid= 10094567 |doi= 10.1002/(SICI)1098-1004(1999)13:2<99::AID-HUMU2>3.0.CO;2-C }} | |||
*{{Cite journal | author=Oetting WS |title=New insights into ocular albinism type 1 (OA1): Mutations and polymorphisms of the OA1 gene. |journal=Hum. Mutat. |volume=19 |issue= 2 |pages= 85–92 |year= 2002 |pmid= 11793467 |doi= 10.1002/humu.10034 }} | |||
*{{ | *{{Cite journal |vauthors=Schnur RE, Trask BJ, van den Engh G |title=An Xp22 microdeletion associated with ocular albinism and ichthyosis: approximation of breakpoints and estimation of deletion size by using cloned DNA probes and flow cytometry. |journal=Am. J. Hum. Genet. |volume=45 |issue= 5 |pages= 706–20 |year= 1989 |pmid= 2573275 |doi= | pmc=1683435 |display-authors=etal}} | ||
*{{ | *{{Cite journal |vauthors=Meindl A, Hosenfeld D, Brückl W |title=Analysis of a terminal Xp22.3 deletion in a patient with six monogenic disorders: implications for the mapping of X linked ocular albinism. |journal=J. Med. Genet. |volume=30 |issue= 10 |pages= 838–42 |year= 1993 |pmid= 8230160 |doi=10.1136/jmg.30.10.838 | pmc=1016566 |display-authors=etal}} | ||
*{{ | *{{Cite journal |vauthors=Schiaffino MV, Bassi MT, Galli L |title=Analysis of the OA1 gene reveals mutations in only one-third of patients with X-linked ocular albinism. |journal=Hum. Mol. Genet. |volume=4 |issue= 12 |pages= 2319–25 |year= 1996 |pmid= 8634705 |doi=10.1093/hmg/4.12.2319 |display-authors=etal}} | ||
*{{Cite journal |vauthors=Schnur RE, Gao M, Wick PA |title=OA1 mutations and deletions in X-linked ocular albinism. |journal=Am. J. Hum. Genet. |volume=62 |issue= 4 |pages= 800–9 |year= 1998 |pmid= 9529334 |doi=10.1086/301776 | pmc=1377018 |display-authors=etal}} | |||
*{{ | *{{Cite journal |vauthors=Rosenberg T, Schwartz M |title=X-linked ocular albinism: prevalence and mutations--a national study. |journal=Eur. J. Hum. Genet. |volume=6 |issue= 6 |pages= 570–7 |year= 1999 |pmid= 9887374 |doi= 10.1038/sj.ejhg.5200226 }} | ||
*{{ | *{{Cite journal |vauthors=d'Addio M, Pizzigoni A, Bassi MT |title=Defective intracellular transport and processing of OA1 is a major cause of ocular albinism type 1. |journal=Hum. Mol. Genet. |volume=9 |issue= 20 |pages= 3011–8 |year= 2001 |pmid= 11115845 |doi=10.1093/hmg/9.20.3011 |display-authors=etal}} | ||
*{{ | *{{Cite journal |vauthors=Bassi MT, Bergen AA, Bitoun P |title=Diverse prevalence of large deletions within the OA1 gene in ocular albinism type 1 patients from Europe and North America. |journal=Hum. Genet. |volume=108 |issue= 1 |pages= 51–4 |year= 2001 |pmid= 11214907 |doi=10.1007/s004390000440 |display-authors=etal}} | ||
*{{ | *{{Cite journal |vauthors=Strausberg RL, Feingold EA, Grouse LH |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 | pmc=139241 |display-authors=etal}} | ||
*{{ | *{{Cite journal |vauthors=Touloukian CE, Leitner WW, Schnur RE |title=Normal tissue depresses while tumor tissue enhances human T cell responses in vivo to a novel self/tumor melanoma antigen, OA1. |journal=J. Immunol. |volume=170 |issue= 3 |pages= 1579–85 |year= 2003 |pmid= 12538723 |doi= 10.4049/jimmunol.170.3.1579| pmc=2241741 |display-authors=etal}} | ||
*{{Cite journal |vauthors=Basrur V, Yang F, Kushimoto T |title=Proteomic analysis of early melanosomes: identification of novel melanosomal proteins. |journal=J. Proteome Res. |volume=2 |issue= 1 |pages= 69–79 |year= 2003 |pmid= 12643545 |doi=10.1021/pr025562r |display-authors=etal}} | |||
*{{ | *{{Cite journal |vauthors=Camand O, Boutboul S, Arbogast L |title=Mutational analysis of the OA1 gene in ocular albinism. |journal=Ophthalmic Genet. |volume=24 |issue= 3 |pages= 167–73 |year= 2003 |pmid= 12868035 |doi=10.1076/opge.24.3.167.15605 |display-authors=etal}} | ||
*{{ | *{{Cite journal |vauthors=Mayeur H, Roche O, Vêtu C |title=Eight previously unidentified mutations found in the OA1 ocular albinism gene. |journal=BMC Med. Genet. |volume=7|pages= 41 |year= 2006 |pmid= 16646960 |doi= 10.1186/1471-2350-7-41 | pmc=1468396 |display-authors=etal}} | ||
*{{ | *{{Cite journal |vauthors=Sallmann GB, Bray PJ, Rogers S |title=Scanning the ocular albinism 1 (OA1) gene for polymorphisms in congenital nystagmus by DHPLC. |journal=Ophthalmic Genet. |volume=27 |issue= 2 |pages= 43–9 |year= 2006 |pmid= 16754205 |doi= 10.1080/13816810600677834 |display-authors=etal}} | ||
*{{ | *{{Cite journal |vauthors=Chi A, Valencia JC, Hu ZZ |title=Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes. |journal=J. Proteome Res. |volume=5 |issue= 11 |pages= 3135–44 |year= 2007 |pmid= 17081065 |doi= 10.1021/pr060363j |display-authors=etal}} | ||
*{{ | {{Refend}} | ||
*{{ | |||
*{{ | ==External links== | ||
*{{ | * [https://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=x-oa GeneReviews/NCBI/NIH/UW entry on Ocular Albinism, X-Linked] | ||
}} | |||
{{ | |||
{{G protein-coupled receptors}} | {{G protein-coupled receptors}} | ||
{{DEFAULTSORT:Gpr143}} | |||
[[Category:G protein coupled receptors]] | [[Category:G protein coupled receptors]] | ||
{{ | |||
{{transmembranereceptor-stub}} |
Revision as of 08:58, 31 August 2017
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
Ocular albinism type 1 protein | |||||||||
---|---|---|---|---|---|---|---|---|---|
Identifiers | |||||||||
Symbol | Ocular_alb | ||||||||
Pfam | PF02101 | ||||||||
Pfam clan | CL0192 | ||||||||
InterPro | IPR001414 | ||||||||
|
G-protein coupled receptor 143 is a protein encoded by the GPR143 gene in humans.[1][2][3]
Ocular albinism type 1 protein is a conserved integral membrane protein with seven transmembrane domains. It is expressed in the eye and epidermal melanocytes.[3]
The GPR143 gene is regulated by the Microphthalmia-associated transcription factor.[4][5]
L-DOPA is an endogenous ligand for OA1.[6]
Interactions
GPR143 has been shown to interact with GNAI1.[2]
References
- ↑ Bassi MT, Schiaffino MV, Renieri A, De Nigris F, Galli L, Bruttini M, Gebbia M, Bergen AA, Lewis RA, Ballabio A (Sep 1995). "Cloning of the gene for ocular albinism type 1 from the distal short arm of the X chromosome". Nat Genet. 10 (1): 13–9. doi:10.1038/ng0595-13. PMID 7647783.
- ↑ 2.0 2.1 Schiaffino MV, d'Addio M, Alloni A, Baschirotto C, Valetti C, Cortese K, Puri C, Bassi MT, Colla C, De Luca M, Tacchetti C, Ballabio A (Sep 1999). "Ocular albinism: evidence for a defect in an intracellular signal transduction system". Nat Genet. 23 (1): 108–12. doi:10.1038/12715. PMID 10471510.
- ↑ 3.0 3.1 "Entrez Gene: GPR143 G protein-coupled receptor 143".
- ↑ Vetrini F, Auricchio A, Du J, et al. (2004). "The microphthalmia transcription factor (Mitf) controls expression of the ocular albinism type 1 gene: link between melanin synthesis and melanosome biogenesis". Mol. Cell. Biol. 24 (15): 6550–9. doi:10.1128/MCB.24.15.6550-6559.2004. PMC 444869. PMID 15254223.
- ↑ Hoek KS, Schlegel NC, Eichhoff OM, et al. (2008). "Novel MITF targets identified using a two-step DNA microarray strategy". Pigment Cell Melanoma Res. 21 (6): 665–76. doi:10.1111/j.1755-148X.2008.00505.x. PMID 19067971.
- ↑ Lopez VM, Decatur CL, Stamer WD, Lynch RM, McKay BS (September 2008). Barsh GS, ed. "L-DOPA is an endogenous ligand for OA1". PLoS Biol. 6 (9): e236. doi:10.1371/journal.pbio.0060236. PMC 2553842. PMID 18828673.
Further reading
- Oetting WS, King RA (1999). "Molecular basis of albinism: mutations and polymorphisms of pigmentation genes associated with albinism". Hum. Mutat. 13 (2): 99–115. doi:10.1002/(SICI)1098-1004(1999)13:2<99::AID-HUMU2>3.0.CO;2-C. PMID 10094567.
- Oetting WS (2002). "New insights into ocular albinism type 1 (OA1): Mutations and polymorphisms of the OA1 gene". Hum. Mutat. 19 (2): 85–92. doi:10.1002/humu.10034. PMID 11793467.
- Schnur RE, Trask BJ, van den Engh G, et al. (1989). "An Xp22 microdeletion associated with ocular albinism and ichthyosis: approximation of breakpoints and estimation of deletion size by using cloned DNA probes and flow cytometry". Am. J. Hum. Genet. 45 (5): 706–20. PMC 1683435. PMID 2573275.
- Meindl A, Hosenfeld D, Brückl W, et al. (1993). "Analysis of a terminal Xp22.3 deletion in a patient with six monogenic disorders: implications for the mapping of X linked ocular albinism". J. Med. Genet. 30 (10): 838–42. doi:10.1136/jmg.30.10.838. PMC 1016566. PMID 8230160.
- Schiaffino MV, Bassi MT, Galli L, et al. (1996). "Analysis of the OA1 gene reveals mutations in only one-third of patients with X-linked ocular albinism". Hum. Mol. Genet. 4 (12): 2319–25. doi:10.1093/hmg/4.12.2319. PMID 8634705.
- Schnur RE, Gao M, Wick PA, et al. (1998). "OA1 mutations and deletions in X-linked ocular albinism". Am. J. Hum. Genet. 62 (4): 800–9. doi:10.1086/301776. PMC 1377018. PMID 9529334.
- Rosenberg T, Schwartz M (1999). "X-linked ocular albinism: prevalence and mutations--a national study". Eur. J. Hum. Genet. 6 (6): 570–7. doi:10.1038/sj.ejhg.5200226. PMID 9887374.
- d'Addio M, Pizzigoni A, Bassi MT, et al. (2001). "Defective intracellular transport and processing of OA1 is a major cause of ocular albinism type 1". Hum. Mol. Genet. 9 (20): 3011–8. doi:10.1093/hmg/9.20.3011. PMID 11115845.
- Bassi MT, Bergen AA, Bitoun P, et al. (2001). "Diverse prevalence of large deletions within the OA1 gene in ocular albinism type 1 patients from Europe and North America". Hum. Genet. 108 (1): 51–4. doi:10.1007/s004390000440. PMID 11214907.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Touloukian CE, Leitner WW, Schnur RE, et al. (2003). "Normal tissue depresses while tumor tissue enhances human T cell responses in vivo to a novel self/tumor melanoma antigen, OA1". J. Immunol. 170 (3): 1579–85. doi:10.4049/jimmunol.170.3.1579. PMC 2241741. PMID 12538723.
- Basrur V, Yang F, Kushimoto T, et al. (2003). "Proteomic analysis of early melanosomes: identification of novel melanosomal proteins". J. Proteome Res. 2 (1): 69–79. doi:10.1021/pr025562r. PMID 12643545.
- Camand O, Boutboul S, Arbogast L, et al. (2003). "Mutational analysis of the OA1 gene in ocular albinism". Ophthalmic Genet. 24 (3): 167–73. doi:10.1076/opge.24.3.167.15605. PMID 12868035.
- Mayeur H, Roche O, Vêtu C, et al. (2006). "Eight previously unidentified mutations found in the OA1 ocular albinism gene". BMC Med. Genet. 7: 41. doi:10.1186/1471-2350-7-41. PMC 1468396. PMID 16646960.
- Sallmann GB, Bray PJ, Rogers S, et al. (2006). "Scanning the ocular albinism 1 (OA1) gene for polymorphisms in congenital nystagmus by DHPLC". Ophthalmic Genet. 27 (2): 43–9. doi:10.1080/13816810600677834. PMID 16754205.
- Chi A, Valencia JC, Hu ZZ, et al. (2007). "Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes". J. Proteome Res. 5 (11): 3135–44. doi:10.1021/pr060363j. PMID 17081065.
External links
This transmembrane receptor-related article is a stub. You can help Wikipedia by expanding it. |